Life sciences companies generate enormous amounts of information that must be managed, analyzed and delivered in a wide variety of formats in order to unlock its true value. Created and used by everyone from bench chemists to clinical trial nurses to contact center representatives, this information is spread across hundreds of disparate applications. With the exponential growth of information within the enterprise, it has become nearly impossible to locate the right information in a timely manner, resulting in redundant content, lower productivity, and increased risk of regulatory non-compliance.

In order to achieve an integrated view of the information in disparate information sources and increase the value of their enterprise content, life sciences companies rely on MarkLogic. Unlike relational database and search-hybrid solutions, MarkLogic Server recognizes and leverages both the content’s existing, high-value structure and its text to deliver solutions with the industry’s deepest text analytics and the most advanced search and discovery. This allows companies to not only shorten the overall drug development process, but also reduce costs through the reuse of existing research data to identify new applications for existing drugs and drug candidates that never made it to market.

Drug Development

Throughout the product development life cycle, researchers must be able to analyze content from a variety of internal sources such as content management and clinical trial management systems, and external sources such as MeSH and MedlinePlus, to make rapid, well-informed decisions regarding drug product candidates. With MarkLogic Server’s ability to integrate content from virtually any source “as is” and inspect both the text and structure of the content, solutions can be deployed rapidly, at lower cost, and with more effective search and discovery capabilities than those based on traditional search and database technologies.

In addition to search and discovery solutions, MarkLogic accelerates the overall drug development process with analytic solutions that enable researchers to analyze lab and clinical trial results in real time, identify issues and opportunities, and take action. For example, with the ability to compare results early in a clinical trial, researchers can match adverse reactions with sub-populations of trial participants, use that knowledge to improve future trials, and enhance the drug candidate’s chances of success. Similarly, researchers can analyze and mine the results of past drugs that failed at any point in the lifecycle, identify similar relationships, and target those drugs at diseases and sub-populations for which they were effective. Or, they can “fail faster” by identifying road blocks earlier in the life cycle, and save millions of dollars.

Contact Centers

The contact centers of life sciences companies deal with potentially life threatening situations on a daily basis. In order to provide accurate, fast responses to questions about drug interactions, incorrect dosages and other adverse events, they must be able to find relevant product information spread across numerous information sources. Integrating that content into a single MarkLogic solution enables company representatives to locate the precise, context-sensitive answers they need, rather than returning a list of links that they must then scan, open and browse through. Auditing capabilities are also provided to ensure compliance with regulatory requirements regarding how a response was provided, along with the information used, and deliver the results in the desired output format.

Industry Expertise

MarkLogic partners with leading system integrators focused on solving complex content-related business problems for the life sciences industry. The powerful combination of MarkLogic’s content aggregation, search and discovery, delivery and custom publishing capabilities combined with the life sciences expertise of our partners results in solutions that yield significant and immediate operational efficiencies. Read more about our life sciences OEM and services partners.